Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana

J Clin Microbiol. 2006 Feb;44(2):468-73. doi: 10.1128/JCM.44.2.468-473.2006.

Abstract

Little information is available about the genetic variability of Leishmania populations and the possible correlations with ecoepidemiological features of leishmaniases. The present study was carried out in French Guiana, a country where cutaneous leishmaniases (CL) are endemic over the whole territory. The genetic polymorphism of a nuclear sequence encompassing the end of the ribosomal small subunit and the internal transcribed spacer 1 of 265 isolates from patients with CL was examined by restriction fragment length polymorphism analysis. Genotypes based on the fingerprinting phenetic integration were compared to epidemiological, clinical, and geographical data. In agreement with previous reports, five different Leishmania species were identified, but Leishmania (Viannia) guyanensis represented 95.8% of the samples. Two distinct L. (V.) guyanensis populations were found to originate in two ecologically characterized regions. Higher lesional parasite densities and the need for additional treatments were significantly linked to genotype group I. Parasites of genotype group II were more likely to cause chronic and disseminated cutaneous forms in patients. L. (V.) guyanensis was previously said not to be very polymorphic; however, the present analysis resulted in a significant degree of discrimination among L. (V.) guyanensis isolates from diverse ecological areas and with different clinical implications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • DNA, Protozoan / analysis
  • DNA, Ribosomal Spacer / analysis
  • Female
  • French Guiana / epidemiology
  • Humans
  • Leishmania guyanensis / classification
  • Leishmania guyanensis / genetics*
  • Leishmania guyanensis / isolation & purification
  • Leishmaniasis, Mucocutaneous / epidemiology*
  • Leishmaniasis, Mucocutaneous / parasitology
  • Male
  • Molecular Epidemiology*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Substances

  • DNA, Protozoan
  • DNA, Ribosomal Spacer